サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1308363

レジオネラ検査市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Legionella Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 139 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
レジオネラ検査市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年07月05日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界のレジオネラ検査市場規模は2022年に2億8,550万米ドルに達しました。今後、IMARC Groupは、市場は2023年から2028年の間に8%の成長率（CAGR）を示し、2028年までに4億5,560万米ドルに達すると予測しています。

レジオネラは下気道を侵す感染症で、重篤な肺炎、ポンティアック熱、インフルエンザのような症状を伴う病気につながる可能性があります。その検査は、血液、尿、喀痰中の細菌または抗原の存在を特定するのに役立ちます。現在、レジオネラ症の診断には、尿中抗原、ペア血清、ポリメラーゼ連鎖反応（PCR）、直接蛍光抗体（DFA）染色、下気道分泌物の培養など、さまざまな検査法が利用可能です。検査結果に応じて、マクロライド、キノロン、テトラサイクリン、ドキシサイクリン、ミノサイクリン、トリメトプリム、その他の抗生物質による治療が患者に行われます。

世界のレジオネラ検査市場動向：

50歳以上の成人はレジオネラを発症しやすいです。その結果、世界の老人人口の増加は、市場にプラスの影響を与える主な要因の1つとなっています。さらに、喫煙者、がん、糖尿病、腎臓病、ヒト免疫不全ウイルス（HIV）、その他の慢性疾患を患う人が増加しており、感染や入院のリスクがあります。レジオネラの死亡率は高いため、その効果的な診断検査と治療に対する需要が増加しています。これに加えて、レジオネラの原因菌は、冷却塔、呼吸療法装置、噴水、ミスト装置、温泉プール、ホテル、家庭、工場の水システムなど、さまざまな自然環境や人工的な水環境で主に発見されています。その結果、多くの国の保健機関は、水中でのレジオネラ菌の増殖を最小限に抑えるために、効果的な水安全計画（WSP）を策定しています。その結果、法規制を遵守するために職場の建物でレジオネラ検査を実施する需要が高まっています。さらに、市中肺炎の成人患者の診断および治療戦略に関する最近の臨床試験が市場の成長に寄与しています。

本レポートで扱う主な質問

  • 2022年の世界のレジオネラ検査市場規模は？
  • 2023～2028年の世界のレジオネラ検査市場の予想成長率は？
  • 世界のレジオネラ検査市場を牽引する主要因は何か？
  • COVID-19が世界のレジオネラ検査市場に与えた影響は？
  • レジオネラ検査の世界市場の用途別区分は？
  • レジオネラ検査の世界市場のエンドユーザー別区分は？
  • レジオネラ検査の世界市場における主要地域は？
  • レジオネラ検査の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のレジオネラ検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：用途別

  • 水質検査
    • 市場動向
    • 市場内訳
      • 微生物培養
      • DFA染色
      • PCR法
      • その他
    • 市場予測
  • IVD検査
    • 市場動向
    • 市場内訳
      • 血液培養
      • 尿中抗原検査
      • DFA染色
      • PCR法
      • その他
    • 市場予測

第7章 市場内訳：エンドユーザー別

  • 診断ラボ
    • 市場動向
    • 市場予測
  • 病院・クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • 欧州
    • イタリア
      • 市場動向
      • 市場予測
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • シンガポール
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • BioMerieux SA
    • Bio-Rad Laboratories Inc
    • Eiken Chemical Co. Ltd
    • Quidel Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Legionella Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Legionella Testing Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Legionella Testing Market: Breakup by Application (in %), 2022
  • Figure 5: Global: Legionella Testing (Water Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 6: Global: Legionella Testing Market for Water Testing: Breakup by Type (in %), 2022
  • Figure 7: Global: Legionella Testing (Water Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 8: Global: Legionella Testing (IVD Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Legionella Testing Market for IVD Testing: Breakup by Type (in %), 2022
  • Figure 10: Global: Legionella Testing (IVD Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Legionella Testing Market: Breakup by End User (in %), 2022
  • Figure 12: Global: Legionella Testing (Diagnostic Laboratory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Legionella Testing (Diagnostic Laboratory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Legionella Testing (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Legionella Testing (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Legionella Testing (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Legionella Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Legionella Testing Market: Breakup by Region (in %), 2022
  • Figure 19: Europe: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Europe: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Europe: Legionella Testing Market: Breakup by Country (in %), 2022
  • Figure 22: Italy: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Italy: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Germany: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Germany: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: France: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: France: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Spain: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Spain: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United Kingdom: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United Kingdom: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Russia: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Russia: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Others: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Others: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: North America: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: North America: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: North America: Legionella Testing Market: Breakup by Country (in %), 2022
  • Figure 39: United States: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia Pacific: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia Pacific: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia Pacific: Legionella Testing Market: Breakup by Country (in %), 2022
  • Figure 46: China: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: China: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Japan: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Japan: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Australia: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Australia: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: South Korea: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: South Korea: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Indonesia: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Indonesia: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Singapore: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Singapore: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Others: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Others: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Latin America: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Latin America: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Latin America: Legionella Testing Market: Breakup by Country (in %), 2022
  • Figure 63: Brazil: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Brazil: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Mexico: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Mexico: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Middle East and Africa: Legionella Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Middle East and Africa: Legionella Testing Market: Breakup by Country (in %), 2022
  • Figure 71: Middle East and Africa: Legionella Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Global: Legionella Testing Industry: SWOT Analysis
  • Figure 73: Global: Legionella Testing Industry: Value Chain Analysis
  • Figure 74: Global: Legionella Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Legionella Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Legionella Testing Market: Breakup by Application (in Million US$), 2017 & 2022
  • Table 3: Global: Legionella Testing Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Legionella Testing Market: Breakup by End User (in Million US$), 2017 & 2022
  • Table 5: Global: Legionella Testing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Legionella Testing Market: Breakup by Region (in Million US$), 2017 & 2022
  • Table 7: Global: Legionella Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Legionella Testing Industry: Key Price Indicator
  • Table 9: Global: Legionella Testing Market: Competitive Structure
  • Table 10: Global: Legionella Testing Market: Key Players
目次
Product Code: SR112023A4020

Market Overview:

The global legionella testing market size reached US$ 285.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 455.6 Million by 2028, exhibiting a growth rate (CAGR) of 8% during 2023-2028.

Legionella is an infection affecting the lower respiratory tract, which can lead to severe pneumonia, Pontiac fever, and illness with flu-like symptoms. Its testing helps to identify the existence of bacteria or antigens in blood, urine, and sputum. Presently, various testing methods are available to diagnose Legionella disease, including urinary antigen, paired serology, Polymerase Chain Reaction (PCR), Direct Fluorescent Antibody (DFA) stain, and culture of lower respiratory secretions. As per the testing results, macrolides, quinolones, tetracycline, doxycycline, minocycline, trimethoprim and other antibiotic treatments are usually administered to patients.

Global Legionella Testing Market Trends:

Adults over the age of 50 years are more likely to develop Legionella. Consequently, the increasing geriatric population worldwide represents one of the major factors influencing the market positively. Moreover, the rising number of individuals who smoke and have cancer, diabetes, kidney disease, human immunodeficiency virus (HIV), or other chronic illnesses are at the risk of infection and hospitalization. Since the mortality rate of Legionella is high, there is an increase in the demand for its effective diagnostic tests and treatments. Besides this, Legionella-causing bacteria are majorly found in different natural and artificial aquatic environments, such as cooling towers, respiratory therapy equipment, fountains, misting devices, spa pools, and water systems in hotels, homes, and factories. As a result, health agencies of numerous countries are developing an effective water safety plan (WSP) to minimize the proliferation of Legionella in the water. This, in turn, is escalating the demand for Legionella testing in workplace buildings to comply with the legislation. Furthermore, recent clinical trials on diagnostic and treatment strategies for adult patients with community-acquired pneumonia are contributing to the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global legionella testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on application and end user.

Breakup by Application:

Water Testing

Microbial Culture

DFA Stain

PCR

Others

IVD Testing

Blood Culture

Urine Antigen Test

DFA Stain

PCR

Others

Breakup by End User:

Diagnostic Laboratories

Hospital and Clinics

Others

Breakup by Region:

Europe

Italy

Germany

France

Spain

United Kingdom

Russia

Others

North America

United States

Canada

Asia Pacific

China

Japan

Australia

South Korea

Indonesia

Singapore

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Becton, Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc, Eiken Chemical Co. Ltd, Quidel Corporation, Takara Bio Inc., and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global legionella testing market in 2022?
  • 2. What is the expected growth rate of the global legionella testing market during 2023-2028?
  • 3. What are the key factors driving the global legionella testing market?
  • 4. What has been the impact of COVID-19 on the global legionella testing market?
  • 5. What is the breakup of the global legionella testing market based on the application?
  • 6. What is the breakup of the global legionella testing market based on the end user?
  • 7. What are the key regions in the global legionella testing market?
  • 8. Who are the key players/companies in the global legionella testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Legionella Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Water Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Microbial Culture
      • 6.1.2.2 DFA Stain
      • 6.1.2.3 PCR
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 IVD Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Breakup by Type
      • 6.2.2.1 Blood Culture
      • 6.2.2.2 Urine Antigen Test
      • 6.2.2.3 DFA Stain
      • 6.2.2.4 PCR
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by End User

  • 7.1 Diagnostic Laboratories
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hospital and Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 Europe
    • 8.1.1 Italy
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Germany
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
    • 8.1.3 France
      • 8.1.3.1 Market Trends
      • 8.1.3.2 Market Forecast
    • 8.1.4 Spain
      • 8.1.4.1 Market Trends
      • 8.1.4.2 Market Forecast
    • 8.1.5 United Kingdom
      • 8.1.5.1 Market Trends
      • 8.1.5.2 Market Forecast
    • 8.1.6 Russia
      • 8.1.6.1 Market Trends
      • 8.1.6.2 Market Forecast
    • 8.1.7 Others
      • 8.1.7.1 Market Trends
      • 8.1.7.2 Market Forecast
  • 8.2 North America
    • 8.2.1 United States
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Canada
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 China
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 Japan
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 Australia
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 South Korea
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Indonesia
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Singapore
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weakness
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porter's Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Becton, Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 BioMerieux SA
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bio-Rad Laboratories Inc
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Eiken Chemical Co. Ltd
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Quidel Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Takara Bio Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 inancials
    • 13.3.8 Thermo Fisher Scientific Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis